Skip to main content
. 2019 Oct 22;20(20):5237. doi: 10.3390/ijms20205237

Figure 2.

Figure 2

Canagliflozin continuous treatment attenuates steatohepatitis and de novo lipogenesis in the liver in STAM mice. (a,b) Representative microphotographs of liver sections stained with hematoxylin eosin and NAFLD activity score (NAS) in the three groups. Original magnification, ×200. Data are mean ± SD. (c) The scores of each component of NAS. (d) mRNA expression of genes involved in lipogenesis.